Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04507516 · ClinicalTrials.gov registry record
Fasting for Brain and Heart Health (FBHH)
A clinical trial of Insulin Resistance, sponsored by TrueNorth Health Foundation.
- Completed
- Registry status
- 48
- Enrollment target
- 1
- Study location
NCT04507516: Completed study of Insulin Resistance, sponsored by TrueNorth Health Foundation.
NCT04507516 is a study of Insulin Resistance that has completed, run by TrueNorth Health Foundation. The registered enrollment target is 48 participants, below the 245-participant average among 120 other Insulin Resistance trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04507516, a study of Insulin Resistance, has completed, sponsored by TrueNorth Health Foundation.
- COMPLETED
- Registry status
- 48 participants
- Enrollment target
- 1
- Study location
Study Summary
This pilot study is designed to investigate the effect of water-only fasting and refeeding on the homeostatic model of insulin resistance (HOMA-IR), a measure of insulin resistance.
Conditions Studied
Interventions
- OTHER Water-only Fasting
Study Locations (1)
California
- TrueNorth Health Center - Santa Rosa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2019-04-02 |
| Est. Completion | 2020-02-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04507516
The ClinicalTrials.gov registry entry for NCT04507516 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 245-participant average among 120 other Insulin Resistance trials with a reported enrollment target (80% lower). The listed sponsor is TrueNorth Health Foundation, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Insulin Resistance appearing as the primary indexed condition, and to 1 intervention - of which Water-only Fasting is the first listed.
NCT04507516 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT04507516 about?
NCT04507516 is a clinical study titled "Fasting for Brain and Heart Health (FBHH)". This pilot study is designed to investigate the effect of water-only fasting and refeeding on the homeostatic model of insulin resistance (HOMA-IR), a measure of insulin resistance.
What is the current status of trial NCT04507516?
This trial is currently completed. The enrollment target is 48 participants. The study started on 2019-04-02. Estimated completion is 2020-02-10.
What conditions does trial NCT04507516 study?
This clinical trial studies the following conditions: Insulin Resistance.
What interventions are being tested in trial NCT04507516?
The interventions under investigation include: Water-only Fasting (OTHER).
Who is sponsoring clinical trial NCT04507516?
This trial is sponsored by TrueNorth Health Foundation, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04507516 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Insulin Resistance
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD
RECRUITING · Phase 2
-
Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
RECRUITING · NA
-
Effect of Weight Loss on Intermuscular Adipose Tissue (IMAT) Signaling
RECRUITING · NA
-
Small Extracellular Vesicles and Insulin Action
RECRUITING · NA
-
Metabolic Effects of Angiotensin-(1-7)
RECRUITING · Phase 1
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.